156 related articles for article (PubMed ID: 24692696)
1. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
3. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
4. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
Attalah KM; Abdalla AN; Aslam A; Ahmed M; Abourehab MAS; ElSawy NA; Gouda AM
Bioorg Chem; 2020 Jan; 94():103371. PubMed ID: 31708230
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel N-phenyl ureidobenzenesulfonate derivatives as potential anticancer agents. Part 2. Modulation of the ring B.
Gagné-Boulet M; Moussa H; Lacroix J; Côté MF; Masson JY; Fortin S
Eur J Med Chem; 2015 Oct; 103():563-73. PubMed ID: 26408815
[TBL] [Abstract][Full Text] [Related]
10. Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.
Cordeu L; Cubedo E; Bandrés E; Rebollo A; Sáenz X; Chozas H; Victoria Domínguez M; Echeverría M; Mendivil B; Sanmartin C; Palop JA; Font M; García-Foncillas J
Bioorg Med Chem; 2007 Feb; 15(4):1659-69. PubMed ID: 17204425
[TBL] [Abstract][Full Text] [Related]
11. Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines.
James DA; Koya K; Li H; Liang G; Xia Z; Ying W; Wu Y; Sun L
Bioorg Med Chem Lett; 2008 Mar; 18(6):1784-7. PubMed ID: 18308566
[TBL] [Abstract][Full Text] [Related]
12. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells.
Liu J; He Y; Zhang D; Cai Y; Zhang C; Zhang P; Zhu H; Xu N; Liang S
Mol Med Rep; 2017 Sep; 16(3):2595-2603. PubMed ID: 28677760
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
14. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
[TBL] [Abstract][Full Text] [Related]
15. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
18. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
Kurumurthy C; Sambasiva Rao P; Veera Swamy B; Santhosh Kumar G; Shanthan Rao P; Narsaiah B; Velatooru LR; Pamanji R; Venkateswara Rao J
Eur J Med Chem; 2011 Aug; 46(8):3462-8. PubMed ID: 21632155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
